An N-terminal fragment of mouse DGAT1 binds different acyl-CoAs with varying affinity

A histidine-tagged recombinant N-terminal fragment of type-1 mouse liver diacylglycerol acyltransferase (DGAT; EC 2.3.1.20), MmDGAT1 (1–95)His6, was expressed in Escherichia coli, and used to investigate possible acyl-CoA-binding properties. Analysis of the purified fragment by MALDI-TOF mass spectr...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 373; no. 3; pp. 350 - 354
Main Authors Siloto, Rodrigo M.P., Madhavji, Milan, Wiehler, William B., Burton, Tracy L., Boora, Parveen S., Laroche, André, Weselake, Randall J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 29.08.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A histidine-tagged recombinant N-terminal fragment of type-1 mouse liver diacylglycerol acyltransferase (DGAT; EC 2.3.1.20), MmDGAT1 (1–95)His6, was expressed in Escherichia coli, and used to investigate possible acyl-CoA-binding properties. Analysis of the purified fragment by MALDI-TOF mass spectrometry revealed a polypeptide with molecular mass of about 11 kDa which was consistent with the calculated molecular mass based on the deduced amino acid sequence. Lipidex-1000 binding assays indicated that MmDGAT1 (1–95)His 6 interacted with long chain fatty acyl-CoAs similar to observations on DGAT1 from oilseed rape ( Brassica napus). Binding, as a function of acyl-CoA concentration, differed for palmitoyl (16:0), stearoyl (18:0), and erucoyl ( cisΔ 1322:1)-CoA. Binding of stearoyl- or erucoyl-CoA to MmDGAT1 (1–95)His 6 as a function of acyl-CoA concentration, however, was sigmoid and displayed positive cooperativity suggesting that MmDGAT1 may be subject to allosteric modulation by acyl-CoAs. An intra-polypeptide segment within the N-terminal region of MmDGAT1 contained remnants of an acyl-CoA-binding signature initially identified in plant DGAT1. The acyl-CoA-binding site in mammalian DGAT1 could represent a potential target for therapeutic interventions for disorders such as type-2 diabetes and obesity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
1090-2104
DOI:10.1016/j.bbrc.2008.06.031